Sarah Tersey to Arachidonate 12-Lipoxygenase
This is a "connection" page, showing publications Sarah Tersey has written about Arachidonate 12-Lipoxygenase.
Connection Strength
1.798
-
Minireview: 12-Lipoxygenase and Islet ß-Cell Dysfunction in Diabetes. Mol Endocrinol. 2015 Jun; 29(6):791-800.
Score: 0.496
-
12-lipoxygenase promotes obesity-induced oxidative stress in pancreatic islets. Mol Cell Biol. 2014 Oct 01; 34(19):3735-45.
Score: 0.474
-
12-Lipoxygenase governs the innate immune pathogenesis of islet inflammation and autoimmune diabetes. JCI Insight. 2021 07 22; 6(14).
Score: 0.192
-
Platelet-type 12-lipoxygenase deletion provokes a compensatory 12/15-lipoxygenase increase that exacerbates oxidative stress in mouse islet ß cells. J Biol Chem. 2019 04 19; 294(16):6612-6620.
Score: 0.163
-
Inhibition of 12/15-Lipoxygenase Protects Against ß-Cell Oxidative Stress and Glycemic Deterioration in Mouse Models of Type 1 Diabetes. Diabetes. 2017 11; 66(11):2875-2887.
Score: 0.147
-
Molecular mechanisms of nonalcoholic fatty liver disease: Potential role for 12-lipoxygenase. J Diabetes Complications. 2017 Nov; 31(11):1630-1637.
Score: 0.146
-
Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development. PLoS One. 2013; 8(2):e56763.
Score: 0.107
-
Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes. Diabetes. 2008 Jan; 57(1):199-208.
Score: 0.074